Real-World Molecular Testing and Treatment Patterns in Brazilian Patients with Newly Diagnosed Locally Advanced or Metastatic NSCLC-Reference-Cited by-同舟云学术

Real-World Molecular Testing and Treatment Patterns in Brazilian Patients with Newly Diagnosed Locally Advanced or Metastatic NSCLC

Published:2020 Issue: Volume:75 Page:
ISSN:1807-5932
Container-title:Clinics
language:en
Short-container-title:

Author:

Cronemberger Eduardo,Baldotto Clarissa,Marinho Felipe,De Marchi Pedro,Araújo Luiz Henrique,Franke Fabio,Salles Paulo,Calabrich Aknar,Almeida Thaís,Custodio Marcelo Graziano,Maria André Santa,Pereira Marcelo Horacio,Castro Gilberto

Publisher

Elsevier BV

Subject

General Medicine

Reference20 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Lung cancer in Brazil;Araujo;J Bras Pneumol,2018

3. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology;Lindeman;Arch Pathol Lab Med,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tiempo al acceso al tratamiento dirigido en cáncer de pulmón de células no pequeñas no escamoso metastásico;Oncología Clínica;2024-04-15

2. The journey of stage III and IV non-small cell lung cancer patients in the Brazilian private healthcare system: a retrospective study;Frontiers in Oncology;2023-10-18

3. Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study;Journal of the Egyptian National Cancer Institute;2023-04-03

4. Assessing Oncologists’ Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil;JTO Clinical and Research Reports;2022-10

5. Survival analysis of young adults from a Brazilian cohort of non-small cell lung cancer patients;ecancermedicalscience;2021-08-24